Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-19-012816
Filing Date
2019-10-30
Accepted
2019-10-30 16:13:20
Documents
61
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q kldo-20190930.htm   iXBRL 10-Q 1884474
2 EX-10.1 kaleidoconsultingandse.htm EX-10.1 62105
3 EX-31.1 exhibit311.htm EX-31.1 13902
4 EX-31.2 exhibit312.htm EX-31.2 14429
5 EX-32.1 exhibit321.htm EX-32.1 13856
11 kldo-20190930_g1.jpg GRAPHIC 127579
  Complete submission text file 0001628280-19-012816.txt   6250574

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT kldo-20190930.xsd EX-101.SCH 31188
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT kldo-20190930_cal.xml EX-101.CAL 55187
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT kldo-20190930_def.xml EX-101.DEF 166382
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT kldo-20190930_lab.xml EX-101.LAB 493684
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT kldo-20190930_pre.xml EX-101.PRE 308883
51 EXTRACTED XBRL INSTANCE DOCUMENT kldo-20190930_htm.xml XML 756782
Mailing Address 18 CROSBY DRIVE BEDFORD MA 01730
Business Address 18 CROSBY DRIVE BEDFORD MA 01730 617-674-9000
Kaleido Biosciences, Inc. (Filer) CIK: 0001751299 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38822 | Film No.: 191180216
SIC: 2836 Biological Products, (No Diagnostic Substances)